Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma

NCT02645149 is registered in ClinicalTrials.gov with Melanoma Institute Australia as lead sponsor.

NCT NCT02645149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02645149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma
Lead sponsor
Melanoma Institute Australia
Phase
Phase 2
Overall status
Completed
Start date
November 22, 2021
Completion date
March 6, 2026
Enrollment
216 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma